Aprotinin use in thoracic aortic surgery: Safety and outcomes

Journal of Thoracic and Cardiovascular Surgery

Volumn 132, Issue 4, 2006, Pages 909-917

  Sedrakyan, Artyom ^a,b   Wu, Albert ^b,c   Sedrakyan, George ^d   Diener West, Marie ^b   Tranquilli, Maryann ^a   Elefteriades, John ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d Nork Marash Medical Center   (Armenia)

Author keywords

[No Author keywords available]

Indexed keywords

APROTININ; LYSINE;

ADULT; AGED; AORTA DISEASE; AORTA DISSECTION; AORTA SURGERY; ARTICLE; BLEEDING; CLINICAL TRIAL; COMORBIDITY; DATA ANALYSIS; DEMOGRAPHY; FEMALE; HEART ARRHYTHMIA; HEMATOMA; HUMAN; LUNG COMPLICATION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; OUTCOME ASSESSMENT; PEROPERATIVE CARE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; REGRESSION ANALYSIS; STATISTICAL ANALYSIS; SURGICAL TECHNIQUE; THORACIC AORTA; THORACIC AORTA ANEURYSM; THORAX SURGERY; THROMBOCYTE TRANSFUSION; TIME SERIES ANALYSIS; TREATMENT OUTCOME; ULCER;

AORTA, THORACIC; AORTIC DISEASES; APROTININ; BLOOD LOSS, SURGICAL; FEMALE; HUMANS; MALE; MIDDLE AGED; SERINE PROTEINASE INHIBITORS;

EID: 33748797164     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2006.06.021     Document Type: Article

References (40)

1. Poli de Figueiredo L.F., and Coselli J.S. Individual strategies of hemostasis for thoracic aortic surgery. J Card Surg 12 (1997) 222-228
2. Cohen J.R., Angus L., Asher A., Chang J.B., and Wise L. Disseminated intravascular coagulation as a result of supraceliac clamping: implications for thoracoabdominal aneurysm repair. Ann Vasc Surg 1 (1987) 552-557
3. Goldstein L.J., Davies R.R., Rizzo J.A., Davila J.J., Cooperberg R., Shaw R.K., et al. Stroke in surgery of the thoracic aorta: incidence, impact, etiology, and prevention. J Thorac Cardiovasc Surg 122 (2001) 935-945
4. Ehrlich M.P., Ergin M.A., McCullough J.N., Lansman S.L., Galla J.D., Bodian C.A., et al. Predictors of adverse outcome and transient neurological dysfunction after ascending aorta/hemiarch replacement. Ann Thorac Surg 69 (2000) 1755-1763
5. Landis R.C., Haskard D.O., and Taylor K.M. New antiinflammatory and platelet-preserving effects of aprotinin. Ann Thorac Surg 72 (2001) S1808-S1813
6. Greilich P.E., Okada K., Latham P., Kumar R.R., and Jessen M.E. Aprotinin but not epsilon-aminocaproic acid decreases interleukin-10 after cardiac surgery with extracorporeal circulation: randomized, double-blind, placebo-controlled study in patients receiving aprotinin and epsilon-aminocaproic acid. Circulation 104 (2001) 1265-1269
7. Mojcik C.F., and Levy J.H. Aprotinin and the systemic inflammatory response after cardiopulmonary bypass. Ann Thorac Surg 71 (2001) 745-754
8. Orchard M.A., Goodchild C.S., Prentice C.R., Davies J.A., Benoit S.E., Creighton-Kremsford L.J., et al. Aprotinin reduces cardiopulmonary bypass-induced blood loss and inhibits fibrinolysis without influencing platelets. Br J Haematol 85 (1993) 533-541
9. Wachtfogel Y.T., Kucich U., Hack C.E., Gluszko P., Niewiarowski S., Colman R.W., et al. Aprotinin inhibits the contact, neutrophil, and platelet activation systems during simulated extracorporeal circulati. J Thorac Cardiovasc Surg 106 (1993) 1-7
10. Van Oeveren W., Harder M.P., Roozendaal K.J., Eijsman L., and Wildevuur C.R.H. Aprotinin protects platelets against the initial effect of cardiopulmonary bypass. J Thorac Cardiovasc Surg 99 (1990) 788-797
11. Sedrakyan A., Treasure T., and Elefteriades J.A. Effect of aprotinin on clinical outcomes in coronary artery bypass graft surgery: a systematic review and meta-analysis of randomized clinical trials. J Thorac Cardiovasc Surg 128 (2004) 442-448
12. Levi M., Cromheecke M.E., de Jonge E., Prins M.H., de Mol B.J., Briet E., et al. Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints. Lancet 354 (1999) 1940-1947
13. Dignan R.J., Law D.W., Seah P.W., Manganas C.W., Newman D.C., Grant P.W., et al. Ultra-low dose aprotinin decreases transfusion requirements and is cost effective in coronary operations. Ann Thorac Surg 71 (2001) 158-163
14. Sundt T.M., Kouchoukos N.T., Saffitz J.E., Murphy S.F., Wareing T.H., and Stahl D.J. Renal dysfunction and intravascular coagulation with aprotinin and hypothermic circulatory arrest. Ann Thorac Surg 55 (1993) 1418-1424
15. Westaby S., Forni A., Dunning J., Giannopoulos N., O'Regan D., Drossos G., et al. Aprotinin and bleeding in profoundly hypothermic perfusion. Eur J Cardiothorac Surg 8 (1994) 82-86
16. Mora Mangano C.T., Neville M.J., Hsu P.H., Mignea I., King J., and Miller D.C. Aprotinin, blood loss, and renal dysfunction in deep hypothermic circulatory arrest. Circulation 104 (2001) 1276-1281
17. Okita Y., Takamoto S., Ando M., Morota T., Yamaki F., Matsukawa R., et al. Coagulation and fibrinolysis system in aortic surgery under deep hypothermic circulatory arrest with aprotinin: the importance of adequate heparinization. Circulation 96 (1997) 376-381
18. Goldstein D.J., DeRosa C.M., Mongero L.B., Weinberg A.D., Michler R.E., Rose E.A., et al. Safety and efficacy of aprotinin under conditions of deep hypothermia and circulatory arrest. J Thorac Cardiovasc Surg 110 (1995) 1615-1622
19. Ehrlich M., Grabenwoger M., Cartes-Zumelzu F., Luckner D., Kovarik J., Laufer G., et al. Operations on the thoracic aorta and hypothermic circulatory arrest: is aprotinin safe?. J Thorac Cardiovasc Surg 115 (1998) 220-225
20. Elefteriades J.A. Natural history of thoracic aortic aneurysms: indications for surgery, and surgical versus nonsurgical risks. Ann Thorac Surg 74 (2002) S1877-S1880 discussion S92-8
21. Peters D.C., and Noble S. Aprotinin: an update of its pharmacology and therapeutic use in open heart surgery and coronary artery bypass surgery. Drugs 57 (1999) 233-260
22. Smith C.R., and Spanier T.B. Aprotinin in deep hypothermic circulatory arrest. Ann Thorac Surg 68 (1999) 278-286
23. Dumont E., Carrier M., Cartier R., Pellerin M., Poirier N., Bouchard D., et al. Repair of aortic false aneurysm using deep hypothermia and circulatory arrest. Ann Thorac Surg 78 (2004) 117-120 discussion 20-1
24. Khan T.A., Bianchi C., Voisine P., Feng J., Baker J., Hart M., et al. Reduction of myocardial reperfusion injury by aprotinin after regional ischemia and cardioplegic arrest. J Thorac Cardiovasc Surg 128 (2004) 602-608
25. Pruefer D., Buerke U., Khalil M., Dahm M., Darius H., Oelert H., et al. Cardioprotective effects of the serine protease inhibitor aprotinin after regional ischemia and reperfusion on the beating heart. J Thorac Cardiovasc Surg 124 (2002) 942-949
26. Hendrikx M., Rega F., Jamaer L., Valkenborgh T., Gutermann H., and Mees U. Na(+)/H(+)-exchange inhibition and aprotinin administration: promising tools for myocardial protection during minimally invasive CABG. Eur J Cardiothorac Surg 19 (2001) 633-639
27. Ad N., Schneider A., Khaliulin I., Borman J.B., and Schwalb H. Impaired mitochondrial response to simulated ischemic injury as a predictor of the development of atrial fibrillation after cardiac surgery: in vitro study in human myocardium. J Thorac Cardiovasc Surg 129 (2005) 41-45
28. Spiess B.D., Royston D., Levy J., Fitch J., Dietrich W., Body S., et al. Platelet transfusions during coronary artery bypass graft surgery are associated with serious adverse outcomes. Transfusion 44 (2004) 1143-1148
29. Stammers A.H., Huffman S., Alonso A., Fristoe L., Hill G., Casebeer D., et al. The antiinflammatory effects of aprotinin in patients undergoing cardiac surgery with cardiopulmonary bypass. J Extra Corpor Technol 29 (1997) 114-122
30. Turkoz A., Cigli A., But K., Sezgin N., Turkoz R., Gulcan O., et al. The effects of aprotinin and steroids on generation of cytokines during coronary artery surgery. J Cardiothorac Vasc Anesth 15 (2001) 603-610
31. Rahman A., Ustunda B., Burma O., Ozercan I.H., Cekirdekci A., and Bayar M.K. Does aprotinin reduce lung reperfusion damage after cardiopulmonary bypass?. Eur J Cardiothorac Surg 18 (2000) 583-588
32. Mossinger H., Dietrich W., Braun S.L., Jochum M., Meisner H., and Richter J.A. High-dose aprotinin reduces activation of hemostasis, allogeneic blood requirement, and duration of postoperative ventilation in pediatric cardiac surgery. Ann Thorac Surg 75 (2003) 430-437
33. Costello J.M., Backer C.L., de Hoyos A., Binns H.J., and Mavroudis C. Aprotinin reduces operative closure time and blood product use after pediatric bypass. Ann Thorac Surg 75 (2003) 1261-1266
34. Augoustides J.G., Lin J., Gambone A.J., and Cheung A.T. Fatal thrombosis in an adult after thoracoabdominal aneurysm repair with aprotinin and deep hypothermic circulatory arrest. Anesthesiology 103 (2005) 215-216
35. Heindel S.W., Mill M.R., Freid E.B., Valley R.D., White II G.C., and Norfleet E.A. Fatal thrombosis associated with a hemi-Fontan procedure, heparin-protamine reversal, and aprotinin. Anesthesiology 94 (2001) 369-371
36. Alvarez J.M., Goldstein J., Mezzatesta J., Flanagan B., and Dodd M. Fatal intraoperative pulmonary thrombosis after graft replacement of an aneurysm of the arch and descending aorta in association with deep hypothermic circulatory arrest and aprotinin therapy. J Thorac Cardiovasc Surg 115 (1998) 723-724
37. Saffitz J.E., Stahl D.J., Sundt T.M., Wareing T.H., and Kouchoukos N.T. Disseminated intravascular coagulation after administration of aprotinin in combination with deep hypothermic circulatory arrest. Am J Cardiol 72 (1993) 1080-1082
38. Fanashawe M.P., Shore-Lesserson L., and Reich D.L. Two cases of fatal thrombosis after aminocaproic acid therapy and deep hypothermic circulatory arrest. Anesthesiology 95 (2001) 1525-1527
39. Seigne P.W., Shorten G.D., Johnson R.G., and Comunale M.E. The effects of aprotinin on blood product transfusion associated with thoracic aortic surgery requiring deep hypothermic circulatory arrest. J Cardiothorac Vasc Anesth 14 (2000) 676-681
40. Parolari A., Antona C., Alamanni F., Spirito R., Naliato M., Gerometta P., et al. Aprotinin and deep hypothermic circulatory arrest: there are no benefits even when appropriate amounts of heparin are given. Eur J Cardiothorac Surg 11 (1997) 149-156